NDT Pharmaceuticals Inc (NDTP)

[ChaseDog31]

The Intellectual Property includes a versatile and widely applicable biotechnology asset base, including the Nanoscale
Particle Complex (“NPC”) technology, which represents the leading edge of phospholipid-based nano-encapsulation
delivery systems (less than 100 nanometers in diameter; mean diameter of 40 nanometers in current liquid product
samples with the capability to engineer significantly smaller nanocarrier particles) that create instant delivery of payloads
into the bloodstream, beginning through the membranes of the mouth. Encapsulated actives are protected from
destruction in the highly acidic environment of the stomach until they reach the small intestine, providing for much
greater absorption of payloads. The instant delivery aspect (an Oral IV) is designed to provide the consumer with rapid
effect upon consumption of the product containing the NPC technology. The NPC technology also incorporates a potent
active ingredient that stimulates repair of damaged cell tissue branded by the Company as “Cell Armor.”


The Company is now focused on developing products utilizing the Intellectual Property.